The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
NeOnc Technologies Partners with CBCC for Clinical Expansion
Apr 01, 2025•about 1 year ago
Contract Type
partnership
CalabasasBiotechnologyHealth CareMedical
Description
NeOnc Technologies Holdings, Inc. announced a strategic partnership with CBCC Global Research to expand clinical trial capabilities in India, focusing on its neuro-oncology treatment. This collaboration will enable NeOnc to conduct trials across 30 FDA-compliant sites in India, accelerating patient enrollment and development efforts for its brain cancer therapies.
Company Information
Company
NeOnc Technologies
Location
23975 PARK SORRENTO
Calabasas, California, United States
About
NeOnc is the developer of a proprietary, patented platform technology that can potentially transport pharma-based therapeutics directly to the brain without the normal boundary restrictions imposed by the body’s Blood-Brain Barrier (BBB). Using NeOnc’s formulations, pharma companies that have limited success with their CNS therapeutics because of current delivery restrictions may be able to provide patients with potentially more effective treatments.
CalabasasBiotechnologyHealth CareMedical